INSM stock

Insmed Inc (INSM) stock news · rev $606.4M

Insmed Inc (INSM) is a biotechnology company listed on US.

This INSM news page leads with what Insmed Inc filed — not a scraped headline mill.

No cached 8-K sentence for INSM yet. We will not pad this page with generic market recap.

Latest reported INSM revenue for 2025-12-31 was $606.4M. Net income was -$1.28B. Revenue was up 66.7% from 2024-12-31 to 2025-12-31. INSM currently screens at market cap $20.42B.

EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.

Not investment advice. For the model open the INSM stock page; for the tape open the quote page.

INSM stock news FAQ

What are INSM's latest revenue and net income?

Latest cached Insmed Inc (INSM) revenue for Dec 31, 2025 was $606.4M. Net income was -$1.28B. Statements: https://lician.com/financials/insm

How did INSM revenue change from the prior cached period?

Cached Insmed Inc (INSM) revenue was up 66.7% from $363.7M (Dec 31, 2024) to $606.4M (Dec 31, 2025). Statements: https://lician.com/financials/insm

What is INSM's market cap?

Insmed Inc (INSM) market cap is $20.42B on the latest cached fundamentals snapshot.

What kind of company is INSM?

Insmed Inc (INSM) is a biotechnology company listed on US.

Where is INSM stock news listed?

Cached stock news for Insmed Inc (INSM) is listed at https://lician.com/news/insm. Filings: https://lician.com/sec/insm

Not investment advice.

Full INSM analysis